Hutchin Hill Capital’s Globus Medical GMED Stock Holding History

Hutchin Hill Capital’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-54,900	Closed	-$1.31M	–	643
2016 Q2	$1.31M	Sell	54,900 -78,100	-59%	-$1.87M	0.04%	244
2016 Q1	$3.16M	Buy	+133,000	New	+$3.25M	0.09%	252
2015 Q1	–	Sell	-99,800	Closed	-$2.37M	–	719
2014 Q4	$2.37M	Buy	+99,800	New	+$2.21M	0.08%	218
2014 Q3	–	Sell	-54,028	Closed	-$1.29M	–	631
2014 Q2	$1.29M	Buy	54,028 +3,928	+8%	+$94.8K	0.06%	292
2014 Q1	$1.33M	Sell	50,100 -19,000	-27%	-$451K	0.07%	304
2013 Q4	$1.39M	Buy	+69,100	New	+$1.28M	0.1%	221

Other funds holding GMED

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

AAM

Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Hutchin Hill Capital's GMED Position: Q3 2016 in Review

Hutchin Hill Capital sold out of Globus Medical (GMED) in Q3 2016, closing a stake of 54,900 shares — an estimated $1.31M sold.

Hutchin Hill Capital first reported a position in GMED in Q4 2013 and held it in 6 quarters. The position peaked at $3.16M in Q1 2016. 196 funds tracked by Wall St. Rank hold GMED as of Q3 2016.

Hutchin Hill Capital reported no remaining Globus Medical position as of Q3 2016 after selling out during the quarter.
Hutchin Hill Capital sold 54,900 Globus Medical shares in Q3 2016, an estimated $1.31M.
Hutchin Hill Capital first reported a position in Globus Medical in Q4 2013 and held it in 6 quarters.
Hutchin Hill Capital's Globus Medical position peaked at $3.16M in Q1 2016.
196 funds tracked by Wall St. Rank held Globus Medical as of Q3 2016.

Based on Hutchin Hill Capital's 13F filing for Q3 2016, filed 14 Nov 2016.